Australia - English - Department of Health (Therapeutic Goods Administration)

pierre fabre australia pty ltd - methylene bis-benzotriazolyl tetramethylbutylphenol, quantity: 40 mg/g; titanium dioxide, quantity: 34.8 mg/g; bemotrizinol, quantity: 20 mg/g; butyl methoxydibenzoylmethane, quantity: 30 mg/g; octocrylene, quantity: 90 mg/g - lotion - excipient ingredients: peg-100 stearate; sorbic acid; pumpkin seed oil; sodium hydroxyethyl acrylate/acryloyldimethyl taurate copolymer; stearyl alcohol; caprylyl glycol; dimeticonol; alkyl (c12-15) benzoate; sorbitan isostearate; 1,3-butylene glycol; decyl glucoside; diisopropyl adipate; tocopheryl glucoside; glyceryl behenate; delta-tocopherol; dimeticone 200; isohexadecane; colloidal anhydrous silica; dimeticone 350; polysorbate 60; caprylic/capric/stearic triglyceride; propylene glycol; xanthan gum; tribehenin; cyclomethicone; potable water; glyceryl monostearate; pvp/eicosene copolymer; disodium edetate; potassium cetyl phosphate; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - cefaclor monohydrate, quantity: 26.22 mg/ml (equivalent: cefaclor, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; erythrosine; sucrose; pregelatinised starch; flavour - ceclor is indicated for the treatment of the following types of infections caused by or likely to be caused by susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory tract infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. ceclor appears to be as effective as phenoxymethyl penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of ceclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - cefaclor monohydrate, quantity: 52.45 mg/ml (equivalent: cefaclor, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; erythrosine; sucrose; pregelatinised starch; flavour - ceclor is indicated for the treatment of the following types of infections caused by or likely to be caused by susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory tract infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. ceclor appears to be as effective as phenoxymethyl penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of ceclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - homosalate, quantity: 100 mg/g; octocrylene, quantity: 65 mg/g; butyl methoxydibenzoylmethane, quantity: 50 mg/g; ethylhexyl triazone, quantity: 35 mg/g; bemotrizinol, quantity: 25 mg/g - lotion - excipient ingredients: acrylates/c10-30 alkyl acrylate crosspolymer; alkyl (c12-15) benzoate; butylated hydroxytoluene; caprylyl glycol; cetyl dimeticone; colloidal anhydrous silica; dibutyl adipate; dimeticone 50; dipotassium glycyrrhizate; disodium edetate; glyceryl monostearate; 1,2-hexanediol; peg-100 stearate; potassium cetyl phosphate; purified water; sodium hydroxide; tropolone; white beeswax; fragrance (perfume) - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 broad spectrum high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Ireland - English - HPRA (Health Products Regulatory Authority)

forest laboratories uk ltd - dimeticone zinc oxide calamine - cream

Malta - English - Medicines Authority

bayer plc - calcium carbonate; dimeticone; magnesium carbonate, heavy - chewable tablet - calcium carbonate 680 mg; dimeticone 25 mg; magnesium carbonate, heavy 80 mg - drugs for acid related disorders

United States - English - NLM (National Library of Medicine)

wal-mart stores, inc - dimeticone 5.0% menthol 0.5%, skin protectant anti-itch - dimethicone 5.0 kg in 100 kg - temporarily relieves itching associated with •minor skin irritation •minor burns •rashes due to poison ivy, oak or sumac •sunburn •temporarily protects and helps relieve chapped or cracked skin •insect bites

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - fluoxetine hydrochloride, quantity: 22.4 mg (equivalent: fluoxetine, qty 20 mg) - capsule, hard - excipient ingredients: titanium dioxide; iron oxide yellow; dimeticone 350; gelatin; patent blue v; pregelatinised maize starch - treatment of major depression. treatment of obsessive compulsive disorder (ocd).

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pancreatic extract, quantity: 150 mg (equivalent: amylase, qty 8000 ph eur unit; equivalent: lipase, qty 10000 ph eur unit; equivalent: protease, qty 600 ph eur unit) - capsule, enteric - excipient ingredients: iron oxide yellow; sodium lauryl sulfate; macrogol 4000; iron oxide black; triethyl citrate; titanium dioxide; cetyl alcohol; dimeticone 1000; gelatin; iron oxide red; hypromellose phthalate - creon is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: cystic fibrosis, chronic pancreatitis, pancreatic surgery, gastrointestinal bypass surgery (eg. bilroth ii gastroenterostomy), ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm)

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pancreatic extract, quantity: 300 mg - capsule, enteric - excipient ingredients: gelatin; cetyl alcohol; dimeticone 1000; iron oxide yellow; sodium lauryl sulfate; hypromellose phthalate; macrogol 4000; iron oxide red; triethyl citrate - creon is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: cystic fibrosis, chronic pancreatitis, pancreatic surgery, gastrointestinal bypass surgery (eg. bilroth ii gastroenterostomy), ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm)